Medtronic Device Deployment System Patent Application
Summary
The European Patent Office published Medtronic's patent application EP4190387A1 for a system deploying medical devices across diseased vessels. The patent application covers prosthetic deployment mechanisms and was published on March 25, 2026 with Medtronic, Inc. as the applicant and Richard S. Ginn as the inventor. The application has been filed designating multiple European states including AT, BE, DE, FR, GB, IT, NL, and others.
What changed
The EPO published Medtronic's patent application EP4190387A1 for a system enabling device deployment to distal locations across diseased vessels. The invention is classified under A61F prosthetics and A61M medical devices, with the application designating 36 European states for potential patent protection. No compliance obligations or deadlines are established by this publication.
Patent publications do not impose regulatory compliance requirements on market participants. Entities with vascular device portfolios should monitor this publication for potential freedom-to-operate considerations. No immediate action is required as this is an application-stage document that does not grant enforceable patent rights.
Source document (simplified)
SYSTEM FOR DEPLOYING A DEVICE TO A DISTAL LOCATION ACROSS A DISEASED VESSEL
Publication EP4190387A1 Kind: A1 Mar 25, 2026
Applicants
Medtronic, Inc.
Inventors
GINN, Richard S.
IPC Classifications
A61M 29/00 20060101AFI20230413BHEP A61M 25/00 20060101ALI20230413BHEP A61F 2/01 20060101ALI20230413BHEP A61F 2/24 20060101ALN20230413BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.